CATY MILANO: Open Payments
NPI 1336866433 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 31 payments from 11 companies in 2025. Trend: 2023 $258 · 2024 $307 · 2025 $593
Food & beverage: $494Education: $99
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 5 | $142 |
| Astellas Pharma US Inc | 4 | $139 |
| MAYNE PHARMA COMMERCIAL LLC | 10 | $113 |
| Exeltis, USA Inc. | 2 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Sage Therapeutics, LLC | 2 | $31 |
| Organon LLC | 2 | $28 |
| CooperSurgical, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $17 |
Products named: ACCRUFER, Veozah, SLYND, MYFEMBREE, ZURZUVAE, NEXPLANON, Paragard T 380A, Mirena.
Industry payments across NJ — which companies pay providers there.
